7.1.2.2.5FCA_IILearning Outcome
Advantages, disadvantages, indications and contraindications of high-flow nasal oxygen (HFNO), non-invasive and invasive positive pressure ventilation
lines 817–818id: LO_7.1.2.2_5_FCA_II
10 items
- 7.1.2.2_5.1FCA_IIVentilation strategies and non-ventilator therapies to optimise oxygenation and ventilation and minimise lung injury
- 7.1.2.2_5.2FCA_IIInitiation of non-invasive ventilation (NIV) and management of patients receiving NIV in the intensive care setting
- 7.1.2.2_5.3FCA_IIRoles and selection of different modes of ventilation, including but not limited to continuous mandatory ventilation, volume control modes, pressure control modes, synchronised intermittent mandatory ventilation, pressure support, *inverse ratio ventilation, continuous positive airway pressure (CPAP), bilevel/airway pressure release ventilation and high-frequency oscillation
- 7.1.2.2_5.4FCA_IIComplications of ventilation and the strategies to minimise ventilator-induced lung injury, including the ventilation of acute respiratory distress syndrome (ARDS) patients
- 7.1.2.2_5.5FCA_IIHaemodynamic effects of positive pressure ventilation (heart-lung interactions)
- 7.1.2.2_5.6FCA_IIPathophysiology of and approach to the management of patient-ventilator dyssynchrony
- 7.1.2.2_5.7FCA_IIInterpret and use blood gas analysis to guide respiratory support
- 7.1.2.2_5.8FCA_IIVentilator graphics (pressure, flow, volume, loops)
- 7.1.2.2_5.9FCA_IIDecisions to wean ventilation, strategies for weaning patients from ventilator support and assessment of success
- 7.1.2.2_5.10FCA_IIDeliberate indications for the use of extracorporeal membrane oxygenation (ECMO) in respiratory failure and the principles of its delivery